Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Jonathan Rigby > Profile

Jonathan Rigby

Affiliations

  • Chief Business Officer at Bioplus Acquisition Corp. (BIOS), 2021-12-03
  • Director at Xeris Pharmaceuticals Inc (XERS), 2019-03-01
  • President And Ceo at Steadymed Ltd. (STDY), 2018-09-04
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
STDY $4.46 4,960 $22,121.60 0 2018-08-30 Filing
STDY $4.46 41,605 $185,558.30 0 2018-08-30 Filing
STDY $4.70 16,994 $79,871.80 41,605 2018-08-24 Filing
STDY $4.73 44,242 $209,215.99 41,605 2018-08-23 Filing
STDY $4.66 88,831 $413,739.27 41,605 2018-08-17 Filing